Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
945 N 5th St
Albemarle, NC 28001Phone+1 980-323-7790Fax+1 704-403-4379
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1997 - 2000
Madigan Army Medical CenterResidency, Internal Medicine, 1994 - 1997
Albany Medical CollegeClass of 1994
Certifications & Licensure
NC State Medical License 2005 - 2025
TX State Medical License 2000 - 2005
PA State Medical License 1996 - 2000- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2002 Dec 01
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 44 citationsA phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomasQuincy Chu, Bahram Forouzesh, Samira Syed, Monica Mita, Garry Schwartz
Investigational New Drugs. 2007-01-20 - 32 citationsA Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV No...Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee, Dominic T. Moore, Jennifer L. Beaumont
Journal of Thoracic Oncology. 2011-09-01 - 9 citationsA case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.Marc Zumberg, Jed B. Gorlin, Elizabeth A. Griffiths, Garry Schwartz, Bradley S. Fletcher
Transfusion. 2020-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
